The Patent Finder

Terms ending in 2042

Pharma Cinq, LLC

Every in-force patent on Pharma Cinq, LLC's record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 12,758,570Uridine Triacetate Amorphous Formulation
In force
 · High confidence
Wellstat Therapeutics CorporationIn forceHigh confidence
US 12,558,368Compositions and Devices for Systemic Delivery of Uridine
In force
 · High confidence
Pharma Cinq, LLCIn forceHigh confidence
US 12,630,5805'-O-Phenylacetyluridine and therapeutic use
In force
 · High confidence
Pharma Cinq, LLCIn forceHigh confidence
3 of 3 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by Pharma Cinq, LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited